Eastman Chemical (NYSE: EMN) reported Q3 EPS of $1.47, $0.02 better than the analyst estimate of $1.45. Revenue for the quarter came in at $2.27 billion versus the consensus estimate of $2.3 billion.

GUIDANCE:

Eastman Chemical sees FY2023 EPS of $6.30-$6.50, versus the consensus of $6.61.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.